Skip to content

Adaptive and Trained Immunity in the Pathogenesis of IgG4-Related Disease

Identification of Adaptive and Trained Immune Mechanisms Driving Tissue Fibrosis in IgG4-Related Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06844864
Acronym
TRIM4
Enrollment
20
Registered
2025-02-25
Start date
2025-03-01
Completion date
2025-09-30
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4 Related Disease

Keywords

Trained immunity

Brief summary

Enquire involvement of trained immunity in the pathogenesis of IgG4RD

Detailed description

Enquire involvement of trained immunity in the pathogenesis of IgG4RD using primary macrophages and co-cultures with patient derived fibroblasts. The investigators will first assess whether macrophages from patients are trained compared to macrophages of healthy controls and then challenge them with IgG from IgG4RD patients to evaluate the functional effects on cultivated fibroblasts.

Interventions

None listed

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients: * Adult subjects \> or = 18 years of age * Subjects capable of providing informed consent * Active IgG4-RD based on the IgG4-related disease activity index * Fulfillment of the 2019 ACR/EULAR Classification Criteria for IgG4RD Healthy Controls: * Adult subjects \> or = 18 years of age * Subjects capable of providing informed consent

Exclusion criteria

Patients and healthy controls: * Subjects \< 18 years of age * Pregnant women * Comorbidities (other ongoing active autoimmune diseases, ongoing cancer, ongoing infections) * Ongoing immunosuppressive therapy

Design outcomes

Primary

MeasureTime frameDescription
Concentration of collagen Ia in the supernant of macrophage/fibroblast co-cultures7 monthsConcentration of collagen Ia (ng/uL) in the supernant of macrophage/fibroblast co-cultures through ELISA assay

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026